|
|
INDICATIONS AND USAGE
Prescription CLOTRIMAZOLE TOPICAL SOLUTION product is indicated for the topical treatment of candidiasis due to Candida albicans and tinea versicolor due to Malassezia furfur.
This formulation is also available as a nonprescription product which is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton fluoccosum, and Microsporum canis.
|
DOSAGE AND ADMINISTRATION
Gently massage sufficient CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% into the affected and surrounding skin areas twice a day, in the morning and evening.
Clinical improvement, with relief of pruritus, usually occurs within the first week of treatment with CLOTRIMAZOLE TOPICAL SOLUTION USP, 1%. If the patient shows no clinical improvement after 4 weeks of treatment with CLOTRIMAZOLE TOPICAL SOLUTION USP, 1%, the diagnosis should be reviewed.
|
HOW SUPPLIED
CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% is supplied in 30 mL plastic bottles (NDC 51672-1260-3); boxes of one.
Store between 2° and 30°C (36° and 86°F).
Rx Only
Mfd. by: TARO Pharmaceuticals Inc. Brampton, Ontario, CANADA L6T 1C1
Revised: December, 2008
PK-1632-3 1208-3 105
|
|
|
|
-- advertisement --
|